Breaking News Instant updates and real-time market news.

MRK

Merck

$83.30

0.52 (0.63%)

, AZN

AstraZeneca

$39.98

0.3 (0.76%)

06:32
06/18/19
06/18
06:32
06/18/19
06:32

Merck, AstraZeneca announce LYNPARZA approved in EU

AstraZeneca (AZN) and Merck (MRK) announced that the European Commission has approved LYNPARZA as monotherapy for the maintenance treatment of adult patients with advanced BRCA1/2-mutated high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response following completion of first-line platinum-based chemotherapy.

MRK

Merck

$83.30

0.52 (0.63%)

AZN

AstraZeneca

$39.98

0.3 (0.76%)

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 24

    Jun

  • 16

    Jul

  • 30

    Jul

  • 06

    Aug

  • 16

    Sep

  • 20

    Sep

MRK Merck
$83.30

0.52 (0.63%)

05/21/19
MSCO
05/21/19
NO CHANGE
Target $84
MSCO
Overweight
Morgan Stanley not lowering Keytruda projections despite Merck disappointment
After Merck announced that Keytruda monotherapy failed to beat chemotherapy in a Phase 3 triple negative breast cancer, or TNBC, trial, Morgan Stanley analyst David Risinger said he is not r lowering his Keytruda projections as he is hopeful that the drug can succeed in KN-355, another TNBC trial, later this year. In that trial, a combination of Keytruda plus chemo will be investigated in first-line TNBC, noted Risinger, who has an Overweight rating and $84 price target on Merck shares.
05/22/19
GUGG
05/22/19
NO CHANGE
GUGG
Buy
Guggenheim says Peloton Therapeutics a good strategic fit for Merck
Guggenheim analyst Seamus Fernandez said he thinks Peloton Therapeutics is a good strategic fit for Merck citing the "rational targeting" of a resistance mechanism to VEGF-TKIs commonly used in the treatment of Renal Cell Carcinoma, or RCC. Fernandez, who sees the transaction being minimally dilutive and having no impact on 2019 adjusted EPS guidance, keeps a Buy rating on Merck shares.
05/28/19
GSCO
05/28/19
INITIATION
Target $85
GSCO
Neutral
Merck initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Terence Flynn started Merck with a Neutral rating and $85 price target. The analyst projects the company's earnings and revenue growth through 2022 will be in-line with consensus. As such, he views the stock as fairly valued.
05/30/19
GUGG
05/30/19
NO CHANGE
GUGG
Buy
Array BioPharma could be seen as target after 'de-risking' data, says Guggenheim
Guggenheim analyst Michael Schmidt said Array Biopharma (ARRY) may be perceived by investors as a theoretical acquisition target following the disclosure of Phase 3 interim results of Braftovi/Mektovi in BRAF+ colorectal cancer, which he views as positive and a "de-risking event." 67% of announced acquisitions in oncology with a comparable market cap to Array had what he would consider major pipeline de-risking events in the 6 months prior to their deal announcements, Schmidt tells investors. Merck (MRK) and Pfizer (PFE) "seem to have most bandwidth for a deal," said Schmidt, who added that those two along with Bristol-Myers (BMY), AstraZeneca (AZN) and Roche (RHHBY) scored highest as possible large cap theoretical acquirers of Array in his analysis. Schmidt raised his price target on Array Biopharma shares to $38 from $37, though his analysis suggests a potential $40-$50 acquisition price if the company were to be bought.
AZN AstraZeneca
$39.98

0.3 (0.76%)

05/29/19
HCWC
05/29/19
NO CHANGE
HCWC
Buy
AstraZeneca decision does not impact MEDI0457, says H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju says AstraZeneca's (AZN) decision to discontinue activities related to two new DNA-based cancer vaccine candidates from Inovio (INO) does not affect MEDI0457. AstraZeneca continues to pursue the development of MEDI0457, which is being evaluated in combination with durvalumab in multiple Phase 2 studies in HPV-related cancers, Selvaraju tells investors in a research note. Inovio is eligible to receive up to $700M potential milestone payments, including $250M related to MEDI0457, says the analyst. He reiterates a Buy rating on Inovio with a $13 price target.
05/29/19
CANT
05/29/19
NO CHANGE
Target $12
CANT
Overweight
Inovio milestones from Astra still worth up to $250M, says Cantor Fitzgerald
Inovio (INO) announced that it received notification from MedImmune, a subsidiary of AstraZeneca (AZN), that it plans to discontinue research collaboration programs except for the MEDI0457/ durvalumab combo studies that are in multiple Phase 2 trials in patients with HPV associated cancers, Cantor Fitzgerald analyst Charles Duncan tells investors in a research note. Despite "strained optics," the collaboration change makes sense, says the analyst. He estimates Inovio's MEDI0457 milestones are worth up to $250M and keeps an Overweight rating on the shares with a $12 price target.
05/30/19
SBSH
05/30/19
NO CHANGE
Target $7
SBSH
Buy
Inovio risk/reward attractive into data readouts, says Citi
Citi analyst Joel Beatty lowered his price target for Inovio Pharmaceuticals (INO) to $7 from $10 after AstraZeneca (AZN) decided to discontinue activities with respect to its rights to co-develop up to two new DNA-based cancer vaccine product candidates. The analyst, however, says this is a good time to buy shares of Inovio. The company has three phase 1/2 immuno-oncology combo trials expected to readout in the second half of 2019, and the stock's risk/reward is attractive into the news, Beatty tells investors in a research note.

TODAY'S FREE FLY STORIES

FL

Foot Locker

$42.72

0.35 (0.83%)

12:25
07/19/19
07/19
12:25
07/19/19
12:25
Options
Foot Locker call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

DIS

Disney

$141.00

-0.62 (-0.44%)

, SNE

Sony

$53.93

-0.02 (-0.04%)

12:21
07/19/19
07/19
12:21
07/19/19
12:21
On The Fly
Box Office Battle: 'Lion King' expected to claim this weekend's throne »

Welcome to "Box Office…

DIS

Disney

$141.00

-0.62 (-0.44%)

SNE

Sony

$53.93

-0.02 (-0.04%)

T

AT&T

$32.91

-0.185 (-0.56%)

CBS

CBS

$51.32

-0.02 (-0.04%)

CMCSA

Comcast

$44.14

-0.42 (-0.94%)

CMCSK

Comcast

$0.00

(0.00%)

LGF.A

Lionsgate

$11.72

0.14 (1.21%)

LGF.B

Lionsgate

$11.05

0.03 (0.27%)

VIA

Viacom

$35.39

0.39 (1.11%)

VIAB

Viacom

$30.79

0.2 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 30

    Jul

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

12:21
07/19/19
07/19
12:21
07/19/19
12:21
Conference/Events
Wolfe Research utilities/midstream analyst to hold a group luncheon »

Utilities & Midstream…

AMRX

Amneal Pharmaceuticals

$3.35

-0.04 (-1.18%)

, BMY

Bristol-Myers

$43.57

-0.47 (-1.07%)

12:18
07/19/19
07/19
12:18
07/19/19
12:18
Hot Stocks
Amneal Pharmaceuticals granted tentative FDA approval of Apremilast »

Amneal Pharmaceuticals…

AMRX

Amneal Pharmaceuticals

$3.35

-0.04 (-1.18%)

BMY

Bristol-Myers

$43.57

-0.47 (-1.07%)

CELG

Celgene

$90.39

-0.51 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 25

    Jul

  • 08

    Aug

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
07/19/19
07/19
12:17
07/19/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
07/19/19
07/19
12:16
07/19/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YGTY

SSLJ.com

$1.18

-0.12 (-9.23%)

12:15
07/19/19
07/19
12:15
07/19/19
12:15
Hot Stocks
Breaking Hot Stocks news story on SSLJ.com »

SSLJ com Ltd (Class A…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$374.39

13.22 (3.66%)

, MSFT

Microsoft

$138.27

1.98 (1.45%)

12:10
07/19/19
07/19
12:10
07/19/19
12:10
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are modestly…

BA

Boeing

$374.39

13.22 (3.66%)

MSFT

Microsoft

$138.27

1.98 (1.45%)

AXP

American Express

$125.00

-3.4 (-2.65%)

GCI

Gannett

$9.62

1.72 (21.77%)

CRWD

Crowdstrike

$83.30

10.55 (14.50%)

SKX

Skechers

$39.35

4.6 (13.24%)

MIK

Michaels

$7.75

-0.62 (-7.41%)

PACB

Pacific Biosciences

$5.23

-0.64 (-10.90%)

ILMN

Illumina

$291.57

-6.97 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 24

    Jul

  • 29

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 03

    Sep

  • 25

    Sep

  • 13

    Nov

CMI

Cummins

$170.04

2.08 (1.24%)

, VWAGY

Volkswagen

$0.00

(0.00%)

12:06
07/19/19
07/19
12:06
07/19/19
12:06
Periodicals
Cummins makes bid for VW's MAN Energy Solutions unit, Reuters says »

Cummins (CMI) has made an…

CMI

Cummins

$170.04

2.08 (1.24%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

SSRM

SSR Mining

$15.69

-0.04 (-0.25%)

12:05
07/19/19
07/19
12:05
07/19/19
12:05
Options
SSR Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

12:05
07/19/19
07/19
12:05
07/19/19
12:05
General news
U.S. Data Slate: The week of July 22 »

U.S. Data Slate: The week…

XOM

Exxon Mobil

$74.86

0.02 (0.03%)

12:04
07/19/19
07/19
12:04
07/19/19
12:04
Periodicals
Exxon Mobil starts process of selling Norwegian oil fields, Bloomberg says »

Exxon Mobil has begun the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

CTK

CooTek

$8.54

-0.02 (-0.23%)

12:00
07/19/19
07/19
12:00
07/19/19
12:00
Hot Stocks
CooTek falls -6.6% »

CooTek is down -6.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHWY

Chewy

$30.63

-2.16 (-6.59%)

12:00
07/19/19
07/19
12:00
07/19/19
12:00
Hot Stocks
Chewy falls -6.8% »

Chewy is down -6.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QEP

QEP Resources

$5.29

-1.02 (-16.16%)

12:00
07/19/19
07/19
12:00
07/19/19
12:00
Hot Stocks
QEP Resources falls -16.2% »

QEP Resources is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$39.22

4.47 (12.86%)

12:00
07/19/19
07/19
12:00
07/19/19
12:00
Hot Stocks
Skechers rises 12.6% »

Skechers is up 12.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFS

Intercorp Financial Services

$45.32

(0.00%)

12:00
07/19/19
07/19
12:00
07/19/19
12:00
Hot Stocks
Intercorp Financial Services rises 17.6% »

Intercorp Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

GCI

Gannett

$9.55

1.65 (20.89%)

12:00
07/19/19
07/19
12:00
07/19/19
12:00
Hot Stocks
Gannett rises 21.1% »

Gannett is up 21.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$89.57

1.92 (2.19%)

, NWSA

News Corp.

$13.21

-0.075 (-0.56%)

11:58
07/19/19
07/19
11:58
07/19/19
11:58
On The Fly
Downgrades of News Corp., Alcoa among today's top analyst calls »

Check out today's top…

PM

Philip Morris

$89.57

1.92 (2.19%)

NWSA

News Corp.

$13.21

-0.075 (-0.56%)

MSGN

MSG Networks

$19.70

-0.52 (-2.57%)

AA

Alcoa

$23.31

-0.11 (-0.47%)

MIK

Michaels

$7.73

-0.64 (-7.65%)

BA

Boeing

$373.56

12.39 (3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Sep

  • 16

    Oct

RCUS

Arcus Biosciences

$8.31

-0.21 (-2.46%)

11:49
07/19/19
07/19
11:49
07/19/19
11:49
Conference/Events
Arcus Biosciences management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 09

    Sep

APO

Apollo Global

$34.96

0.71 (2.07%)

, NTXFY

Natixis

$0.00

(0.00%)

11:48
07/19/19
07/19
11:48
07/19/19
11:48
Periodicals
Apollo approached Coface with buyout offer, Reuters reports »

Apollo Global Management…

APO

Apollo Global

$34.96

0.71 (2.07%)

NTXFY

Natixis

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

YGTY

SSLJ.com

$1.18

-0.12 (-9.23%)

11:47
07/19/19
07/19
11:47
07/19/19
11:47
Hot Stocks
SSLJ.com to withdraw Nasdaq listing »

SSLJ.com Limited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANF

Abercrombie & Fitch

$18.77

0.15 (0.81%)

11:45
07/19/19
07/19
11:45
07/19/19
11:45
Options
Abercrombie & Fitch call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

YGTY

SSLJ.com

$1.18

-0.12 (-9.23%)

11:40
07/19/19
07/19
11:40
07/19/19
11:40
Hot Stocks
Breaking Hot Stocks news story on SSLJ.com »

SSLJ com Ltd (Class A…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$32.93

-0.165 (-0.50%)

, CBS

CBS

$51.39

0.05 (0.10%)

11:39
07/19/19
07/19
11:39
07/19/19
11:39
Hot Stocks
AT&T accuses CBS of trying to 'up-sell' customers to All Access, Deadline says »

AT&T (T) is accusing…

T

AT&T

$32.93

-0.165 (-0.50%)

CBS

CBS

$51.39

0.05 (0.10%)

CBS.A

$51.24

-0.32 (-0.62%)

NXST

Nexstar

$105.19

0.8 (0.77%)

TRCO

Tribune Media

$46.38

(0.00%)

SBGI

Sinclair Broadcast

$55.91

-0.17 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 30

    Jul

  • 07

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 05

    Sep

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.